Company logo

NVST - Envista Holdings Corporation

NYSE -> Healthcare -> Medical Instruments & Supplies
Brea, United States
Type: Equity

NVST price evolution
NVST
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $940 $824.2 $651.7 $585.2
Short term investments
Net receivables $407.5 $417.1 $415.2 $401.8
Inventory $258.8 $278.8 $297 $307.2
Total current assets $1743.7 $1640.7 $1488.9 $1414.3
Long term investments
Property, plant & equipment $434.7 $430.6 $429.7 $430.5
Goodwill & intangible assets $4246.2 $4459.6 $4536.9 $4571.9
Total noncurrent assets $4861.4 $5043.1 $5118.3 $5160.7
Total investments
Total assets $6605.1 $6683.8 $6607.2 $6575
Current liabilities
Accounts payable $179.5 $168.6 $176.8 $186.8
Deferred revenue
Short long term debt $145.6 $144.5 $540 $539.2
Total current liabilities $780.8 $746.8 $1150.8 $1149.6
Long term debt $1508 $1493.3 $992.4 $995.1
Total noncurrent liabilities $1650.4 $1643.8 $1145.4 $1146.4
Total debt $1653.6 $1637.8 $1532.4 $1534.3
Total liabilities $2431.2 $2390.6 $2296.2 $2296
Shareholders' equity
Retained earnings $631.2 $848.6 $827.1 $775.2
Other shareholder equity -$217.2 -$306.8 -$236.9 -$210.6
Total shareholder equity $4173.9 $4293.2 $4311 $4279
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $940 $606.9 $1073.6 $888.9
Short term investments
Net receivables $407.5 $393.5 $331.9 $361
Inventory $258.8 $300.8 $263.8 $266.9
Total current assets $1743.7 $1424.6 $1835.8 $1590.5
Long term investments
Property, plant & equipment $434.7 $425.4 $392.2 $468.3
Goodwill & intangible assets $4246.2 $4583.3 $4178.4 $4689.9
Total noncurrent assets $4861.4 $5162.4 $4738.4 $5285.5
Total investments
Total assets $6605.1 $6587 $6574.2 $6876
Current liabilities
Accounts payable $179.5 $228.3 $185.8 $235.1
Deferred revenue
Short long term debt $145.6 $537 $456.1 $919.3
Total current liabilities $780.8 $1236.7 $1208.2 $1684.7
Long term debt $1508 $870.7 $1003.8 $1061.5
Total noncurrent liabilities $1650.4 $1143.4 $1308 $1470.3
Total debt $1653.6 $1529.1 $1459.9 $1980.8
Total liabilities $2431.2 $2380.1 $2516.2 $3155
Shareholders' equity
Retained earnings $631.2 $731.4 $466.9 $126.4
Other shareholder equity -$217.2 -$225.1 -$143.5 -$91.8
Total shareholder equity $4173.9 $4206.9 $4057.6 $3720.6
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $645.6 $631.3 $662.4 $627.2
Cost of revenue $309.7 $268 $283.8 $264.5
Gross Profit $335.9 $363.3 $378.6 $362.7
Operating activities
Research & development $20.2 $22.3 $26.8 $24.5
Selling, general & administrative $260.2 $257.7 $272.9 $266.1
Total operating expenses $538.7 $280 $299.7 $290.6
Operating income -$202.8 $83.3 $78.9 $72.1
Income from continuing operations
EBIT -$201.1 $51.2 $86 $72.4
Income tax expense $2.4 $14.3 $16.7 $11.9
Interest expense $13.9 $15.4 $17.4 $16.7
Net income
Net income -$217.4 $21.5 $51.9 $43.8
Income (for common shares) -$217.4 $21.5 $51.9 $43.8
(in millions $) 31 Dec 2023 31 Dec 2022 31 Jan 2022 31 Dec 2020
Revenue
Total revenue $2566.5 $2569.1 $2282
Cost of revenue $1126 $1094.3 $1123.9
Gross Profit $1440.5 $1474.8 $1158.1
Operating activities
Research & development $93.8 $100.1 $100.8
Selling, general & administrative $1056.9 $1055.5 $1024
Total operating expenses $1409 $1155.6 $1124.8
Operating income $31.5 $319.2 $33.3
Income from continuing operations
EBIT $8.5 $327.4 $32.4
Income tax expense $45.3 $45.9 -$63.4
Interest expense $63.4 $38.4 $62.5
Net income
Net income -$100.2 $243.1 $33.3
Income (for common shares) -$100.2 $243.1 $33.3
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$217.4 $21.5 $51.9 $43.8
Operating activities
Depreciation $40 $39.6 $40.1 $42.9
Business acquisitions & disposals
Stock-based compensation $4.4 -$1.8 $5.2 $15
Total cash flows from operations $102 $95.5 $75.1 $3.1
Investing activities
Capital expenditures -$2.1 -$18.4 -$14.1 -$17.5
Investments $0.5 $1.1 $10.7
Total cash flows from investing -$12.6 -$25 -$2.8 -$22
Financing activities
Dividends paid
Sale and purchase of stock $3.8 $1.6 $1.3 $4.6
Net borrowings -$0.3 $115.7
Total cash flows from financing $3.3 $114.5 $2.6 -$1.5
Effect of exchange rate $23.1 -$12.5 -$8.4 -$1.3
Change in cash and equivalents $115.8 $172.5 $66.5 -$21.7
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$100.2 $243.1 $340.5 $33.3
Operating activities
Depreciation $162.6 $162.1 $151.9 $163.1
Business acquisitions & disposals -$622.3 $310.4 -$40.7
Stock-based compensation $22.8 $30.5 $28.2 $22.6
Total cash flows from operations $275.7 $182.7 $361.6 $283.9
Investing activities
Capital expenditures -$52.1 -$72.4 -$43.1 -$42.4
Investments $12.3 $56
Total cash flows from investing -$62.4 -$657.3 $262.7 -$69.1
Financing activities
Dividends paid
Sale and purchase of stock $11.3 $21.8 $19.5 $13.8
Net borrowings $115.4 -$0.2 -$478 $479.4
Total cash flows from financing $118.9 $12.5 -$465.6 $492.5
Effect of exchange rate $0.9 -$4.6 $26 -$29.6
Change in cash and equivalents $333.1 -$466.7 $184.7 $677.7
Fundamentals
Market cap $3.67B
Enterprise value $4.38B
Shares outstanding 171.50M
Revenue $2.57B
EBITDA $171.10M
EBIT $8.50M
Net Income -$100.20M
Revenue Q/Q -2.30%
Revenue Y/Y -0.10%
P/E ratio -36.59
EV/Sales 1.71
EV/EBITDA 25.60
EV/EBIT 515.33
P/S ratio 1.43
P/B ratio 0.84
Book/Share 25.60
Cash/Share 5.48
EPS -$0.58
ROA -1.51%
ROE -2.35%
Debt/Equity 0.58
Net debt/EBITDA 8.72
Current ratio 2.23
Quick ratio 1.90